Human neuronal nicotinic acetylcholine receptor compositions and methods employing same
AssigneeMerck & Co., Inc.
InventorsKathryn J. Elliott, Michael M. Harpold
Life of this patent
Estimating the term…
Abstract
Nucleic acid molecules encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing the nucleic acid molecules, and methods for producing alpha and beta subunits are provided. In particular, nucleic acid molecules encoding α6 subunits and molecules encoding β3 subunits of human neuronal nicotinic acetylcholine receptors are provided. In addition, combinations of a plurality of subunits, such as one or more of α1, α2, α3, α4, α5, α6 and/or α7 subunits in combination with one or more of β3 subunits or such as one or more of β2, β3 and/or β4 subunits in combination with an α6 subunit are provided.
Claims3
A substantially pure human neuronal nicotinic acetylcholine α6 subunit encoded by a nucleic acid molecule comprising nucicotides 143–1624 of SEQ ID NO:9.
A substantially pure human neuronal nicotinic acetylcholine receptor, comprising an α6 human neuronal nicotinic acetylcholine receptor subunit, wherein the subunit comprises the amino acid sequence as set in any one of SEQ ID NO:10.
Dependencies are inferred from the claim text.